What did @ltnchangg actually say?
The creator ran through a quick peptide cheat sheet: "If you want muscle go for testosterone" or "CJC plus Ipa," "if you want to lose weight take retatrutide," and "if you want skin, GHK-Cu." That's the whole video. No doses, no context, no caveats. It's essentially a shopping list delivered with the confidence of someone who's done the reading, but the brevity does real damage to accuracy.
The transcript has some obvious audio garbling, "test of more then" is almost certainly "testosterone or" something else, possibly tesamorelin or just testosterone itself. We'll address each claim on its own merits, but the framing deserves scrutiny first: peptide therapy is not a vending machine. Matching a single compound to a single goal ignores pharmacology, individual variation, and in some cases, legal status in the US.
Does the science back this up?
Partially, and only partially. CJC-1295 combined with ipamorelin does have real mechanistic support for growth hormone stimulation, retatrutide's weight-loss data is legitimately impressive in early trials, and GHK-Cu has a reasonable evidence base for skin-related applications. But "the science backs it up" and "you should just go take it" are two very different statements.
CJC-1295 is a growth hormone-releasing hormone analog, and ipamorelin is a ghrelin mimetic. Together they produce synergistic GH pulses. Sigalos and Pastuszak (2018, Sexual Medicine Reviews) reviewed GHRH analogs and noted that while GH secretagogues are used off-label for body composition, the clinical evidence in healthy adults remains limited and long-term safety data is sparse. Retatrutide is a GIP/GLP-1/glucagon triple agonist. Jastreboff et al. (2023, New England Journal of Medicine) showed up to 24% body weight reduction in a Phase 2 trial, which is genuinely striking. But it is still in clinical trials and not FDA-approved as of this writing. GHK-Cu's skin data comes largely from in vitro and animal studies, with some human cosmetic research showing collagen stimulation, but controlled clinical trials in humans are limited.
What did they get wrong (or right)?
Let's be direct. The retatrutide claim is the most problematic. Telling 109,000 viewers to "take retatrutide" for weight loss treats an investigational compound as if it's available at a pharmacy. It is not FDA-approved. Access exists only through compounding pharmacies operating in a legally gray area, and the long-term cardiovascular and endocrine effects are not yet characterized. Framing it as a casual option alongside established peptides is irresponsible, even if the weight-loss data is real.
The CJC plus ipamorelin recommendation for muscle is more defensible as a general category claim. These peptides are widely used in clinical anti-aging and sports medicine contexts. The mechanism is sound. However, "go for CJC plus Ipa" as a muscle-building recommendation skips over the fact that GH secretagogues support recovery and body composition in GH-deficient populations much more clearly than in healthy young adults, where the evidence thins out considerably.
The GHK-Cu skin claim is the most defensible of the three. Pickart and Margolina (2018, Frontiers in Aging Neuroscience) documented GHK-Cu's role in collagen synthesis and wound healing, though most robust data is still preclinical. Credit where it's due: it's not a wild claim, just an incomplete one.
What should you actually know?
Peptides are not interchangeable wellness supplements, and a 15-second TikTok is not a clinical consultation. Here's what the video left out entirely. First, retatrutide is investigational. Anyone accessing it outside a clinical trial is doing so through compounding, with no FDA-verified safety or purity standards on that specific product. Second, CJC-1295 and ipamorelin affect the hypothalamic-pituitary axis. That is not a system to tinker with based on a social media tip. Third, GHK-Cu is available in topical and injectable forms with very different evidence profiles. Topical cosmetic use is one thing; injectable use is another.
Every single one of these compounds requires a prescriber evaluation, baseline labs, and ongoing monitoring to be used responsibly. FormBlends operates as a regulated telehealth platform precisely because these conversations need a licensed clinician in the loop, not a comment section. If a video makes peptide selection sound as simple as picking a flavor, that's a signal to slow down, not click add to cart.